Sorry, you need to enable JavaScript to visit this website.
Skip to main content

Back

Bristol-Myers Squibb Patient Assistance Foundation, Inc.

This independent, nonprofit organization provides assistance to qualifying patients with financial hardship who generally have no prescription insurance.

CoverOne™

Provides access and reimbursement support to patients taking BAVENCIO® (avelumab) injection in the United States.

CoverOne is brought to you by EMD Serono Inc. and Pfizer Inc.

CUTAQUIG® (Immune Globulin Subcutaneous (Human) - hipp) Co-pay or Savings card*

Assists eligible patients with their co-pay costs.

*Terms and conditions apply. In some cases, patients may be only eligible for this co-pay or savings card if their prescription plan covers the Pfizer medicine they’ve been prescribed.

Eucrisa-4-you Savings and Support

Helps patients understand their insurance for EUCRISA® (crisaborole) ointment, 2%, and also helps eligible patients save on their medicine.

*Patients must be at or below 400% of the Federal Poverty Level, adjusted for family size, to qualify for free medicine through the Pfizer Patient Assistance Program. Additional program eligibility applies. Please contact the program directly for more information.

Myfembree®

The Myfembree® Support Program is designed to help your patients throughout their treatment journey. We offer financial assistance options, dedicated support staff, and other helpful resources once patients have been prescribed Myfembree®.

In this resource, the various components of the program will be described in detail to ensure that patients understand which offerings, if any, they are eligible for.

Call 1-833-MYFEMBREE (1-833-693-3627)

Pfizer Bridge Program

Helps eligible patients access GENOTROPIN® (somatropin) for injection and SOMAVERT® (pegvisomant) for injection.

*Patients must be at or below 500% of the Federal Poverty Level, adjusted for family size, to qualify for free medicine through the Pfizer Patient Assistance Program. Additional program eligibility applies. Please contact the program directly for more information.

Pfizer enCompass™

Offers comprehensive reimbursement and patient support services for patients treated with Pfizer Biosimilars.

*Patients must be at or below 500% of the Federal Poverty Level, adjusted for family size, to qualify for free medicine through the Pfizer Patient Assistance Program. Additional program eligibility applies. Please contact the program directly for more information.

Pfizer Hemophilia Connect

Provides patients who have been prescribed BeneFIX® Coagulation Factor IX (Recombinant), or XYNTHA® Antihemophilic Factor (Recombinant) with access to relevant Pfizer tools and programs based on their individual needs.

*Patients must be at or below 500% of the Federal Poverty Level, adjusted for family size, to qualify for free medicine through the Pfizer Patient Assistance Program. Additional program eligibility applies. Please contact the program directly for more information.

Pfizer Oncology Together

Provides patients with financial assistance and personalized support for their Pfizer oncology medicines:

AROMASIN® (exemestane) tablets, BESPONSA™ (inotuzumab ozogamicin), BOSULIF® (bosutinib) tablets, BRAFTOVI® (encorafenib) capsules, CAMPTOSAR® (irinotecan hydrochloride) injection, DAURISMO™ (glasdegib) tablets, ELLENCE® (epirubicin hydrochloride) injection, EMCYT® (estramustine phosphate sodium) capsules, IBRANCE® (palbociclib) capsules, IDAMYCIN PFS® (idarubicin hydrochloride) injection, INLYTA® (axitinib) tablets, LORBRENA® (lorlatinib) tablets, MEKTOVI® (binimetinib) tablets, MYLOTARG™ (gemtuzumab ozogamicin) for injection, NIVESTYM® (filgrastim-aafi) injection, NYVEPRIA™ (pegfilgrastim-apgf) injection, RETACRIT® (epoetin alfa-epbx) injection, RUXIENCE™ (rituximab-pvvr) injection, SUTENT® (sunitinib malate) capsules, TALZENNA® (talazoparib) capsules, TORISEL® (temsirolimus) injection, TRAZIMERA™ (trastuzumab-qyyp) for injection, VIZIMPRO® (dacomitinib) tablets, XALKORI® (crizotinib) capsules, and ZIRABEV™ (bevacizumab-bvzr) injection

Pfizer Vaccines Reimbursement Support Services

Helps verify patients’ insurance benefits and their understanding of coverage requirements for PREVNAR 13® (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]), TRUMENBA® (Meningococcal Group B Vaccine) and Prevnar 20™ (Pneumococcal 20-valent Conjugate Vaccine).

Pfizer IGuide provides reimbursement and financial assistance to eligible patients who have been prescribed Panzyga or Cutaquig.

Pfizer IGuide Phone: 1-844-448-4337, Fax: 1-844-868-6329, Hours: Monday-Friday (excluding holidays) 8 am to 8 pm ET.

VyndaLink

Helps eligible patients who have been prescribed VYNDAQEL® (tafamidis meglumine) or VYNDAMAX™ (tafamidis) understand their insurance coverage, research financial assistance resources, and identify third-party resources that may be available.

*Patients must be at or below 500% of the Federal Poverty Level, adjusted for family size, to qualify for free medicine through the Pfizer Patient Assistance Program. Additional program eligibility applies. Please contact the program directly for more information.

XELSOURCE℠

Provides assistance to eligible patients who have been prescribed XELJANZ® (tofacitinib) tablets/XELJANZ® XR (tofacitinib) extended-release tablets.

*Patients must be at or below 500% of the Federal Poverty Level, adjusted for family size, to qualify for free medicine through the Pfizer Patient Assistance Program. Additional program eligibility applies. Please contact the program directly for more information.

ZYVOXassist

Provides financial assistance to eligible patients who have been prescribed oral ZYVOX® (linezolid).

*Patients must be at or below 400% of the Federal Poverty Level, adjusted for family size, to qualify for free medicine through the Pfizer Patient Assistance Program. Additional program eligibility applies. Please contact the program directly for more information.